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Introduction — Conventional cardiovascular risk factors account for a 
major part of cardiovascular diseases. Different arterial parameters 
called “integrators” seem to become risk factors of their own, 
mostly by integrating deleterious factors over decades of evolution. 
Individualization of these factors could lead to a better management 
of patients in primary or secondary prevention.
Objective — Which integrator arterial parameters are the most 
discriminative in a population with hypertensive patients in primary 
or secondary prevention?
Material and methods — We studied clinical, haemodynamical, 
anthropometrical, and biological data from 348 patients (185 men and 
163 women). These hypertensive patients entered the day hospital 
for a cardiovascular checkup, because of cardiovascular risk factors. 
We measured brachial and central blood pressure, augmentation 
index, and pulse wave velocity (PWV) and anthropometric data.
Results — Among those patients, 283 were in primary prevention 
and 65 in secondary prevention.
Mean results in patients in secondary prevention show the following 
data: they are signifi catively older, more often of masculine gender, 
they have a higher tobacco consumption, a lower LDL-cholesterol 
level, a higher creatinine level, a higher mean blood pressure 
(MBP), a lower heart rate (HR), a higher pulse wave velocity 
(PWV). There is no signifi cant difference either for intima-media 
thickness (IMT), or for carotid plaque prevalence. Lower results for 
LDL-cholesterol and heart rate are due to a higher prescription of 
statins and betablockers.
Conclusion — PWV is more discriminant than IMT or plaque 
prevalence in this population and would be a better integrator of 
cardiovascular risk.
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Introduction — Metabolic syndrome (MetS) is a cluster of cardiovascular 
risk factors accounting for a growing part of cardiovascular diseases. 
Different arterial parameters described as integrators seem to 
be individualized as cardiovascular risk factors by themselves by 
integrating the effects longing since decades. The specifi c part of 
each component of metabolic syndrome makes more effi cient the 
management of these patients.
Objective — Do patients with metabolic syndrome (MetS) 
have arterial hemodynamical modifi cations and to which MetS 
components are they most closely linked?
Material and methods — We studied in 2008 clinical, 
haemodynamical, anthropometrical, and biological data from 
348 patients (185 men and 163 women). These hypertensive patients 
entered the day hospital for a cardiovascular checkup, because of 
the presence of cardiovascular risk factors. We measured brachial 
and central blood pressure, augmentation index, and pulse wave 
velocity (PWV) and anthopometrical data.
Results — Among these patients, 150 did have a metabolic syndrome 
(MetS+) and 198 did not (MetS-).
 Age Male Diabetes LDL-C Tobacco Creatinin MBP HR PWV plaques IMT MetS
Primary 
prevention 57±13 48% 36% 2.88±0.9 8±13 81±30 117±19 74±13 12.8±3.8 41% 0.44±0.05 41%
Secondary 
prevention
66±6 74% 48% 2.36±0.9 17±24 103±52 111±17 70±12 14.2±4.1 49% 0.44±0.06 51%
p= <0.05 <0.05 0.07 <0.05 <0.05 <0.05 <0.05 <0.05 <0.05 0.37 0.94 0.17
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PWV is higher in MetS+ patients who also are older and have 
a higher mean blood pressure (MBP) and heart rate (HR). 
Nevertheless, the relationship between MetS and arterial stiffness 
does not sustain after adjustment with confounding factors 
such as age, gender, arterial pressure, and heart rate. Multiple 
parameter correlation of PWV with each of MetS components 
show a signifi cant statistical difference with glucose metabolism 
impairment only.
 Age Male Creat MBP HR PWV
MetS+ 57±15 54% 84±33 114±17 71±12 13.7±3.1
MetS- 62±12 52% 88±40 120±20 76±13 12.6±2.6
p= <0.05 0.7 0.26 <0.05 <0.05 <0.05
Conclusion — MetS+ patients have a higher PWV than MetS- patients.
When performing multiple parameter relationship with different 
components of metabolic syndrome, we fi nd that only glucose 
metabolism impairment is independently and positively correlated 
to carotid-femoral PWV.
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Introduction — Diabetes accounts for a large part of cardiovascular 
complications. Arterial tree alteration is the cornerstone and 
haemodynamical parameters are impaired.
Objective — Which are carotido-femoral pulse wave velocity 
determinants in a day hospital diabetic population having cardio-
vascular check-up?
Methods — We studied from January to July 2008 clinical, 
haemodynamical, anthropometrical, and biological data from 
348 patients (185 men and 163 women) at the Diagnosis and 
Therapeutics Center at the Hôtel-Dieu of Paris, France. These 
hypertensive patients entered the day hospital in order to have a 
cardiovascular checkup, because of the presence of one or several 
cardiovascular risk factors. We measured brachial and central blood 
pressure, augmentation index, and pulse wave velocity (PWV). We 
measured their waist and hip circumferences, studied their body 
composition, calculated their intima-media thickness. They also 
had extended biochemical tests.
Results — Among those 348 patients, 132 (38%) had diabetes (7% for 
type 1 and 93% for type 2). Mean period of diabetes was 5 years. 
Treatments combined insulin (18%), biguanids (21%), acarbose (4%), 
sulfamids (12%), thiazolidinediones (4%). Among those patients, 
there was a signifi cant positive relationship between pulse wave 
velocity and glycosylated hemoglobin (r=0.31, p<0.05). This 
relationship was present after confounding factors adjustment 
(age, arterial pressure, gender, heart rate).
Conclusion — Diabetes control quality is an independant factor of 
arterial wall rigidifi cation.
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Introduction — Metabolic syndrome (MetS) which is a cluster of 
biological, anthropometrical, and heamodynamical cardiovascular risk 
factors paves the way to cardiovascular morbidity and mortality.
Objective — Are hemodynamical parameters impaired as metabolic 
syndrome components cluster?
Material and methods — We studied from January to July 2008 
clinical, haemodynamical, anthropometrical, and biological data 
from 348 patients (185 men and 163 women) at the Diagnosis and 
Therapeutics Center at the Hôtel-Dieu of Paris, France. These 
hypertensive patients entered the day hospital in order to have a 
cardiovascular checkup, because of the presence of one or several 
cardiovascular risk factors. We measured brachial and central blood 
pressure, augmentation index, and pulse wave velocity (PWV). We 
measured their waist and hip circumferences, studied their body 
composition, calculated their intima-media thickness. They also had 
extended biochemical tests.
Results — Our study population was composed with 147 patients 
with (MetS+ ) and 196 without (MetS-) metabolic syndrome.
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PWV differs as metabolic syndrome components cluster 
(p ANOVA<0.01).
Nevertheless there is no statistical signifi cant difference between 
PWV and MetS components after adjustment with classical PWV 
determinants (age, gender, blood pressure, heart rate).
Conclusion — PWV gets higher as MetS components cluster but this 
elevation is not independently linked to classic PWV determinants 
such as age and blood pressure.
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LA RÉADAPTATION CARDIO-VASCULAIRE 
APRÈS INFARCTUS DU MYOCARDE REPERFUSÉ 
AU STADE AIGU : ANALYSE DES CARACTÉRISTIQUES 
DE PRESCRIPTION ET DES RÉSULTATS 
À MOYEN TERME
VIRGINIE HEROGUELLE, SOPHIE TASSAN-MANGINA, 
PIERRE NAZEYROLLAS, CHARLES MOUTON, LAURA KRAPF, 
DAMIEN METZ
CHU de Reims, Cardiologie, Reims, France
Rationnel — De nombreuses études ont démontré l’intérêt de la 
rééducation cardiaque après infarctus du myocarde. Qu’en est-il des 
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caractéristiques de prescription et des bénéfi ces chez les patients 
qui ont eu une reperfusion myocardique initiale réussie ?
Protocole — Registre prospectif monocentrique incluant tous les 
patients hospitalisés au CHU de Reims du 17/02/07 au 25/08/07 
pour syndrome coronarien aigu avec sus-décalage persistant du 
segment ST et élévation de la troponine et qui ont bénéfi cié d’une 
reperfusion au stade aigu par thrombolyse et/ou angioplastie. La 
proposition de rééducation cardiaque était laissée au libre choix du 
cardiologue référent, elle comprenait 20 séances de réentraînement 
à l’effort. Un suivi téléphonique était réalisé à 6 mois.
Résultats — Ont été inclus 73 hommes et 19 femmes âgés de 59,6 
± 12,3 ans (38 à 87 ans). La fraction d’éjection ventriculaire gauche 
était normale (>50%) dans 61 % des cas, modérément altérée (30 à 
50 %) dans 33 % des cas. La rééducation a été proposée à 62 patients 
(67,4 % de la population), plus fréquemment aux hommes (77 % de 
la population masculine ; 32 % de la population féminine ; p = 0,001) 
et aux sujets de moins de 60 ans (80 % des moins de 60 ans ; 54 % 
des 61 ans et plus ; p = 0,028). La rééducation était acceptée dans 
87 % des cas. La situation professionnelle, les facteurs de risque, la 
fonction systolique VG n’avaient pas d’infl uence sur la proposition 
de rééducation.
Quatre-vingt sept pourcent des patients débutant le cycle de 
rééducation l’ont achevé. La tolérance fonctionnelle à l’effort, 
évaluée par test d’effort en début et fi n de programme, était 
signifi cativement améliorée après rééducation (p < 0,001).
À 6 mois, les patients rééduqués bénéfi ciaient plus souvent d’un 
traitement médicamenteux BASIC (78 % vs 57 % ; p = 0,03). Ils avaient 
tendance à reprendre plus souvent leur activité professionnelle, à 
débuter ou à reprendre plus souvent une activité sportive. Il n’y 
avait par contre pas de différence entre les 2 groupes en termes de 
sevrage tabagique et de réduction pondérale.
Conclusion — La rééducation cardiaque est bénéfi que à moyen 
terme chez les patients revascularisés avec succès au stade aigu de 
leur infarctus du myocarde. Elle reste cependant sous-prescrite en 
particulier chez les femmes et les sujets âgés et n’a pas d’impact 
sur le sevrage tabagique.
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ACCURACY OF A PORTABLE INTERNATIONAL 
NORMALIZED RATIO MONITOR IN PATIENTS 
RECEIVING A LOW MOLECULAR WEIGHT HEPARIN 
AS A BRIDGING ANTICOAGULANT
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N. RENAUD, A. BEN DRISS
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Background — Point of care (POC) devices are accurate in stable 
patients receiving a vitamin-K-antagonist (VKA) for a long time 
but their effi ciency has not been prospectively assessed during 
the bridging period were patients are receiving a VKA and a low 
molecular weight heparin (LMWH) until that the target INR is 
reached.
Methods — 188 duals INR measurement using the POC (INR-poc) 
and the laboratory (INR-lab) at the same time were consecutively 
determined: 69 in patients receiving LMWH + VKA (bridging 
group) and 119 in patients receiving only a VKA (control group) 
INR-poc was compared to INR-lab which was considered as the 
reference.
Results — Test strip failure rate (“outliers”) was higher in the 
bridging group (29% vs 4%; p<0,001) than in the control group.
In successful tests, POC accuracy was as good in the bridging group 
as in the control group. Indeed, 94% of dual INR measurement were 
within 0,5 INR units in the bridging group versus 80% in the control 
group (p=0,02) and the relative measure of divergence (RMD=INR-
lab - INR-poc/INR-lab) was higher in the control group than in the 
bridging group (10±14% vs 4±7%; p=0,02).Moreover, agreement 
coeffi cient (AC) between INR-lab and INR-poc was determined 
for laboratory ranges<2,0; 2,0 -3,0; 3,1 -4,0 and >4,0. AC was of 
74% in the bridging group vs 70% in the control group.Correlation 
coeffi cients for INR-poc and INR-lab values were of 0.81 in the 
bridging group and 0.87 in the control group.
Importantly, clinically relevant agreement (same VKA dosing 
adjustment decisions) between POC and laboratory was of 90% in 
the bridging group and 92,1% in the control group (p=0.6).
Finally, the only parameter correlated with the divergence between 
the two measures was the magnitude of INR.
Conclusion — With the POC used (INRatio), in patients receiving 
LMWH 1 the number of test strip failure is high (29%) but 2 when 
the POC gives a result, it is as accurate as in patients not receiving 
a LMWH.
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We investigated whether an age-dependent increase in arterial 
stiffness was associated with an increased reactivity of the clotting 
system in vitro. We studied 123 apparently healthy women over 
60. Aortic stiffness was assessed by carotid-femoral pulse wave 
velocity (PWV). Thrombin generation and its limitation by activated 
protein C (APC) were assessed by thrombography. Free tissue factor 
pathway inhibitor (TFPI), von Willebrand factor (vWF) and factor VIII 
were quantifi ed in plasma. Women aged over 70 had higher levels 
of pulse pressure, PWV, vWF, free TFPI and factor VIII than women 
aged 60-64. Rate and peak of thrombin generation increased with 
age with no increase in endogenous thrombin potential without 
APC (ETP0). This may refl ect an increase in free TFPI counteracting 
thrombin formation driven by increased factor VIII and vWF. Neither 
ETP0 nor APC sensitivity were correlated with PWV. There was a 
strong correlation between PWV and both free TFPI and vWF even 
after adjustment for age. Multiple regressions identifi ed for the 
fi rst time PWV as an independent determinant of free TFPI but not 
of vWF concentration. We surmise that, in apparently healthy aged 
women, the TFPI increase that accompanies vascular wall stiffening 




WHAT’S ABOUT RELATIONSHIP BETWEEN 
CARDIOVASCULAR RISK FACTORS 
AND TYPE OF BLOOD GROUP
MYRIEM AGREBI
Faculté des sciences de tunis, biologie, Tunis, Tunisie
To determine the relationship between risk factors and type of 
blood group, we studied and compared clinical, biological and 
genetical (phenotype of blood group) parameters in 210 cardiac 
patients, aged 34-54 years, with different blood groups.
In the fi rst group, 94 patients had ‘O’blood group, in the second 
group: 58 patients had ‘B’blood group, in the third group: 50 
patients had ‘A’blood group and in the fourth group: 8 patients had 
“AB” blood group.
Our study showed that (89%) of the blood group “A”, 3 patients 
from 8 of the blood group “AB” are touched by the organic heart 
disease, against (58%) of the blood group “O”.
We took the initiative to distinguish between the patients having 
an organic cardiac pathology and the patients having a functional 
cardiac pathology on the same type of blood group. By analyzing in 
our work, the clinical evolution at the patients, affected by an organic 
chronic cardiac pathology, we noticed that 63% of the blood group 
“A” have bad pronostic without signifi cant difference between blood 
group “O” and “B”. 6 patients from 8 of the blood group “AB” has a 
severe pronostic. This observation is based on clinical and biological 
argumentations and proved by reliable statistics. Our work revealed 
that the gene “A” is the most affected by the cardiovascular risk 
factors. Indeed, patients of blood group A are: (67%) hyperlipemia, 
(44%) diabetic, (39%) hypertension and (17%) obese.
In fact, we found that this difference results a correct correlation 
between hypercholesterolemia level and lower alkaline 
phosphatase level in patients in “A” blood group and between 
lower hypercholesterolemia level and higher alkaline phosphatase 
in patients of “O” blood group. This alkaline phosphatase level is 
genetically determined.
Conclusion — Our study showed that cardiovascular risk factors, 
specially, for the blood group “A”, are often depending of the type 
of blood group.
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NORMAL DIAMETER OF THE ASCENDING AORTA 
MUST NOT LEAD TO UNDERESTIMATE THE RISK 
FOR AORTIC DISSECTION DUE TO DIFFUSE AORTIC 
FRAGILITY IN MARFAN SYNDROME
LEA MIMOUN, DELPHINE DETAINT, GUILLAUME JONDEAU, 
ALEC VAHANIAN
Hôpital Bichat Claude Bernard, Paris, France
Objective — In Marfan syndrome (MFS), aortic risk is evaluated 
through measure of ascending aortic dilatation. However, due to 
diffuse aortic wall anomaly, descending aortic dissection (DAD) 
can also occur. The risk for this event is not directly evaluated 
in practice: it is generally felt that the risk for descending aortic 
dissection is absent when aortic root is not dilated.
We report the diameter of ascending aorta at the time or after the 
occurrence of dissection limited to descending aorta in patients 
with MFS.
Methods and result — Among 819 patients with a diagnostic of MFS 
based on the Ghent criteria of our out-patient clinic, 66 patients 
had a history of DAD: mean age at the time of dissection was 40±11 
years, 32 were males (48%).
The entire aorta was dissected for 46 of them (70%). Mean age 
at the time of dissection was: 40±12years, 23 were males (50%). 
Dissection of only descending aorta occurred in 20 patients. Mean 
age at the time of dissection was 41±11years, 9 were males (45%) 
similar to patients with dissection of the entire aorta (p>0.70 
for both). Out of these 20 patients, 7 (33%) had previous surgery 
for dilatation of ascending aorta. Aortic diameter at the level of 
Valsalva sinuses ranged from 28 to 47mm (mean 40±5mm) in the 13 
remaining patients. Among them aortic diameter was≥45 mm in only 
2 patients. For the 11 remaining patient, i.e. 55% of the patients 
with isolated DAD, maximal aortic diameter ranged between 28 
and 42mm (mean 37±3mm), i.e. normal values when normalized 
according to Roman nomograms During the follow up of 5.2±3.9 
years the rate of death or surgery was 24%±11 at 5 years.
Conclusion — We show that in patients with MFS, half of isolated 
dissection of descending aorta occurs despite normal diameter 
of ascending aorta. Therefore all patients with MFS should be 
considered at risk for aortic dissection and should benefi t from 
preventive therapy (including beta-blockers).
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KINETICS AND PROGNOSTIC VALUE OF D-DIMER 
IN ACUTE AORTIC DISSECTION
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Introduction — Diagnostic value of circulating D-Dimer (DD) in 
acute aortic dissection (AAD) has been shown recently, particularly 
due to high sensibility and negative predictive value of this test, 
like in venous thrombo-embolic disease. However, there is no data 
available concerning the kinetics of DD in AAD and few is known 
about in-hospital and long term prognostic value of DD in AAD.
Objectives — To describe the kinetics of circulating DD during the 
in-hospital period of AAD in patients undergoing or not surgery 
and to analyse the prognostic value of this biomarker on morbi-
mortality during the in-hospital period and at long term.
Patients and methods — Consecutive patients presenting with AAD 
in our institution and at least one dosage of DD during hospital 
course were included retrospectively between 1997 and 2004 and 
prospectively between 2004 and 2007. Follow-up was obtained to 
determine the total mortality and major events related to AAD i.e.: 
re-intervention, aneurismal evolution, persistence of a circulating 
false lumen). DD were assessed by immunoturbidimetric method 
(Stago®, France).
Results — 109 patients (mean age 62±14 years) were included. 
76 patients were Stanford A (70%, surgery in 97%), and 33 Stanford 
B (30%, surgery in 9%). DD levels at admission were 10032±7955 
ng/ml. The kinetic of DD followed a “V” curve with a signifi cant 
decrease until day 2 (nadir) and a slow increase thereafter up 
to day 8 without difference between the type of dissection or 
82 Abstracts
whether the patients were operated or not. Cumulative mortality 
was 16% in-hospital and 28% at a mean of follow up 3.4±3 years. In-
hospital mortality was associated with DD level at admission and at 
day2 (nadir). Cumulative long-term mortality was only associated 
with DD level at day 2 (nadir) at the cut off of 2000ng/ml. DD 
were not associated with re-intervention, aneurismal evolution or 
persistence of a circulating false lumen.
Conclusion — DD kinetic in AAD follows a biphasic “V” curve, with 
a nadir at day 2. In hospital mortality is associated with DD at 
admission and at day2, whereas cumulative long-term mortality is 
only associated with DD levels at day 2. These results suggest that 
a DD dosage at admission and at day 2 in AAD might be of help for 
the patient prognosis evaluation.
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PRESCRIPTIONS MÉDICAMENTEUSES 
ET VALIDATION DES OBJECTIFS DE PRÉVENTION 
CARDIOVASCULAIRE EN CAS D’INSUFFISANCE 
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DAMIEN METZ1
1 CHU REIMS - Hôpital Robert Debré, 
Cardiologie et pathologies vasculaires, Reims, France 
2 CHU REIMS - Hôpital Maison Blanche, 
Département de Néphrologie et Dialyse Rénale, Reims, France
Introduction — Les pathologies cardiovasculaires (CV) représentent 
la principale cause de morbi-mortalité en cas d’insuffi sance rénale 
chronique (IRC). Pour autant, la prise en charge thérapeutique CV 
est souvent incomplète.
Méthodes — Nous avons étudié, dans une cohorte de patients avec 
IRC sévère (clairance 15-30 ml/mn) stables suivis en consultation, 
les traitements à impact CV prescrits et la validation des objectifs 
proposés par les recommandations.
Résultats — 71 patients (64 % hommes) âgés de 72 ± 14 ans, ont été 
inclus. La clairance moyenne était de 21,9 ml/mn. 44 % avaient des 
antécédents de maladie athéromateuse. Hypertension artérielle, 
diabète, dyslipidémie, surpoids, tabagisme et hérédité vasculaire 
étaient présents dans 82, 35, 42, 56, 37 et 9 % des cas respectivement. 
La plupart des patients cumulaient les facteurs de risque.
Diurétiques, bloqueurs du système rénine-angiotensine (BSRA), 
inhibiteurs calciques, bétabloqueurs, centraux et dérivés 
nitrés étaient prescrits dans 68, 77, 51, 41, 28 et 11 % des cas 
respectivement. Nombre de patients recevaient plusieurs anti-
hypertenseurs (0, 1, 2, 3 et 4 ou +, chez respectivement 8, 11, 
23, 24 et 35 % des patients). 62 % n’étaient pas aux objectifs 
tensionnels (<130/80).
51% des patients traités par BSRA et 25 % des non traités avaient 
une protéinurie > 0,5 g/j.
Le LDL-cholestérol était > 1 g/l chez 40 % des patients sous statines 
et 59 % des patients non traités. 76 % des patients avec LDL > 1 g/l 
n’avaient pas de statines.
En prévention secondaire de maladie athéromateuse, BSRA, 
antiagrégants plaquettaires et statines étaient prescrits chez 
respectivement 84, 64, et 39 % des patients. 26 % recevaient les 
3 traitements.
Discussion/conclusion — Malgré une morbi-mortalité CV élevée 
et de nombreux facteurs de risque, les objectifs fi xés par l’HAS 
(tension artérielle < 130/80, protéinurie < 0,5 g/j) sont rarement 
atteints en cas d’IRC sévère, malgré les nombreux traitements 
prescrits, notamment BSRA. De plus BSRA, antiagrégants et statines 
pourtant préconisés chez ces patients à haut risque CV sont sous-
utlisés en prévention secondaire
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L’AUTOMESURE TENSIONNELLE EST FAISABLE 
CHEZ LE DIABÉTIQUE DE TYPE 2 HYPERTENDU
NOURA ZANNAD1, NICOLE FERREIRA-MALDENT2
1 CHU DE TOURS, CARDIOLOGIE B, Chambray Les Tours, France 
2 CHU DE TOURS, Médecine interne B. Médecine vasculaire 
et diabétologie, Chambray Les Tours, France
Introduction — L’automesure tensionnelle permet une amélioration 
de l’observance du traitement antihypertenseur et une augmentation 
du nombre de patients atteignant les objectifs tensionnels. 
Plusieurs études ont montré une bonne faisabilité de l’automesure 
tensionnelle, mais celle-ci n’a jamais été étudiée spécifi quement 
chez l’hypertendu diabétique.
Objectif — Notre étude a pour but d’évaluer la faisabilité de 
l’automesure tensionnelle chez l’hypertendu diabétique.
Méthodes — 64 patients diabétiques de type 2 hypertendus 
traités ont été inclus consécutivement pour réaliser un protocole 
d’automesure tensionnelle. Le critère d’évaluation principal 
était le nombre de patients réalisant plus de 80 % des mesures 
demandées.
Résultats — 61,5 % des patients ont fait plus de 80 % des mesures 
demandées. L’âge > 72 ans (OR 0,17 ; IC 95 % : 0,048 × 0,62 ; p = 0,007) 
et le sexe masculin (OR 3,1 ; IC95 % : 1,01 × 9,71 ; p = 0,046) étaient 
indépendamment associés à la faisabilité. La corrélation entre les 
chiffres tensionnels obtenus par la mesure clinique et en automesure 
était bonne aussi bien pour la pression artérielle systolique (r = 0,56, 
IC95 % : 0,32 × 0,73, p < 0,0001) que pour la pression artérielle 
diastolique (r = 0,63, IC95 % : 0,62 × 0,78, p < 0,0001). L’automesure 
permettait d’identifi er 10 patients ayant une HTA masquée, et 
5 patients ayant une HTA « blouse blanche ».
Conclusion — L’automesure tensionnelle est faisable et fi able chez 
l’hypertendu diabétique de type 2. Cette méthode devrait être 
utilisée plus souvent car la prévalence de l’HTA masquée et de 
l’HTA « blouse blanche » est élevée dans cette population.
